--2025/Q1-- / 3.250M--
--2024/Q4-- / 5.230M--
--2024/Q30.000 / 7.118M--
--2024/Q20.000 / 1.358M--
--2024/Q1591.000K / 912.500K--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
PRME Prime Medicine
- 2.900
- +0.110+3.94%
Close Dec 20 16:00 ET
- 2.900
- 0.0000.00%
Post 20:01 ET
380.37MMarket Cap-1.41P/E (TTM)
3.050High2.730Low2.45MVolume2.760Open2.790Pre Close7.19MTurnover3.82%Turnover RatioLossP/E (Static)131.16MShares9.80052wk High2.01P/B186.00MFloat Cap2.56052wk Low--Dividend TTM64.14MShs Float21.730Historical High--Div YieldTTM11.47%Amplitude2.560Historical Low2.936Avg Price1Lot Size
Prime Medicine Key Stats
Prime Medicine Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Prime Medicine Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data